Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(14):958-959; doi:10.1093/jnci/djj316
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Whitworth, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitworth, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Ten Years Later: Liver Cancer Treatment Reevaluated

Ariel Whitworth

The first 10% of the full text of this article appears below.

New treatment options for some liver cancers may mean that liver transplants are fading out of style.

Ten years ago, JNCI reported that liver transplants were becoming the treatment option of choice for patients diagnosed with an early stage of a type of liver cancer called hepatocellular carcinoma (HCC) [See JNCI, 1996;88:632–633.]. Today some scientists believe that the preferred treatment method is shifting again. They suggest that therapies that destroy tumor cells without surgery . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?